Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.morepen.com | |
Market Cap | 1,867.81 Cr. | |
Enterprise Value(EV) | 1,836.67 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.93 | Trailing Twelve Months Ending 2023-06 |
Price-Earning Ratio (PE) | 39.18 | Trailing Twelve Months Ending 2023-06 |
Industry PE | 37.95 | Trailing Twelve Months Ending 2023-06 |
Book Value / Share | 15.02 | Trailing Twelve Months Ending 2023-06 |
Price to Book Value | 2.43 | Calculated using Price: 36.54 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 51.12 Cr. | 511,168,708 Shares |
FaceValue | 2 | |
About Morepen Laboratories Ltd. | ||
Established in the year 1984, Morepen Laboratories is a fast growing Pharmaceutical company listed in all major stock exchanges in India including Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) since 1993 with an investors base of 62,400 shareholders. |
1 Day |
|
-0.46% |
1 Week |
|
-2.43% |
1 Month |
|
-1.38% |
3 Month |
|
+17.00% |
6 Month |
|
+46.16% |
1 Year |
|
+15.45% |
2 Year |
|
-37.65% |
5 Year |
|
+41.63% |
10 Year |
|
+1209.68% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 1.24 | 7.35 | 12.54 | 14.10 | 12.04 | 12.50 | 29.20 | 21.79 | 5.93 | |
Return on Capital Employed (%) | 2.90 | 6.29 | 10.18 | 14.05 | 10.01 | 12.05 | 27.13 | 24.86 | 8.40 | |
Return on Assets (%) | 0.44 | 2.53 | 4.45 | 5.30 | 4.80 | 5.25 | 12.76 | 10.55 | 3.55 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Shh. Funds | 297 | 287 | 300 | 196 | 226 | 253 | 284 | 425 | 579 | 753 | |
Non Curr. Liab. | 85 | 74 | 57 | 18 | 20 | 23 | 28 | 30 | 36 | 37 | |
Curr. Liab. | 108 | 128 | 167 | 325 | 340 | 339 | 351 | 404 | 456 | 321 | |
Minority Int. | 0 | 0 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |
Equity & Liab. | 490 | 489 | 524 | 538 | 586 | 615 | 663 | 858 | 1,070 | 1,111 | |
Non Curr. Assets | 393 | 374 | 367 | 346 | 342 | 316 | 291 | 331 | 336 | 354 | |
Curr. Assets | 96 | 115 | 157 | 192 | 243 | 299 | 372 | 527 | 734 | 756 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 490 | 489 | 524 | 538 | 586 | 615 | 663 | 858 | 1,070 | 1,111 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
Net Sales | 401 | 485 | 595 | 607 | 769 | 853 | 1,188 | 1,547 | 1,418 | 1,516 | |
Other Income | 1 | 1 | 4 | 4 | 4 | 9 | 12 | 20 | 6 | 8 | |
Total Income | 402 | 486 | 599 | 610 | 772 | 863 | 1,200 | 1,567 | 1,424 | 1,524 | |
Total Expenditure | -352 | -424 | -534 | -542 | -701 | -785 | -1,070 | -1,410 | -1,338 | -1,425 | |
PBIDT | 50 | 63 | 65 | 68 | 71 | 78 | 131 | 157 | 86 | 99 | |
Interest | -9 | -11 | -8 | -4 | -2 | -2 | -2 | -2 | -2 | -2 | |
Depreciation | -39 | -35 | -34 | -34 | -40 | -37 | -30 | -28 | -28 | -29 | |
Taxation | 0 | 0 | 0 | -6 | -1 | -25 | -17 | -20 | |||
Exceptional Items | -4 | ||||||||||
PAT | 2 | 13 | 24 | 30 | 29 | 34 | 97 | 102 | 39 | 48 | |
Minority Interest | 0 | 0 | |||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 2 | 13 | 24 | 30 | 29 | 34 | 97 | 102 | 39 | 48 | |
Adjusted EPS | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 34 | 51 | 50 | 41 | 63 | 17 | 11 | 51 | -60 | -91 | |
Cash Fr. Inv. | -1 | -32 | -27 | -14 | -27 | -13 | -12 | -70 | -32 | -47 | |
Cash Fr. Finan. | -29 | -19 | -27 | -24 | -38 | 0 | 5 | 47 | 66 | 144 | |
Net Change | 4 | 0 | -4 | 3 | -1 | 4 | 4 | 28 | -26 | 6 | |
Cash & Cash Eqvt | 9 | 9 | 4 | 7 | 6 | 10 | 14 | 41 | 16 | 22 |
Thu, 21 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached details of loss of share certificates. |
Wed, 20 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Please find attached issue of letter of confirmation w.r.t. issue of duplicate shares. |
Tue, 19 Sep 2023
Announcement under Regulation 30 (LODR)-Change in Management Mr. Varun Suri Senior Management Personnel of the company has taken over the responsibilities of Morepen Rx Limited Wholly Owned Subsidiary of the company and ceases to be on the payrolls of the Morepen Laboratories Limited. |
Thu, 21 Sep 2023 |
|
|
|
|
|